95: COVID Fight Podcast: Vaccine protection wanes in 6 months, says study; when will we get back to normal?
The World Health Organization’s chief scientist Soumya Swaminathan has said that India may be entering the endemic stage, which is when a population learns to live with a virus. She added that she hop...
25 Aug 20216min
94: COVID Fight Podcast: Now book vaccine slots via WhatsApp; will India get booster shot soon?
An expert panel, which says the third wave of COVID-19 can hit the country anytime between September and October, has said the country does not have sufficient data to decide on the need for a booster...
24 Aug 20217min
93: COVID Fight Podcast: Economic recovery roots deepened in July; 'lockdowns can't go on forever', says Australian PM
As COVID-19-related restrictions were eased across the country, roots of economic recovery deepened in July 2021, a report by ICRA Ratings said. The unlocking in the country has manifested itself in i...
23 Aug 20217min
92: COVID Fight Podcast: Zydus Cadila’s vaccine gets regulator nod; is India prepared for 3rd wave?
Zydus Cadila’s three-dose COVID-19 vaccine ZyCoV-D received emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) on August 20. Adolescents in the age group of 12-18 years...
20 Aug 20216min
91: Market Unplugged Podcast: CarTrade good company, but IPO a case of bull market greed
The market had been giving signs of an impending correction from the beginning of the month when the number of declining stocks steadily started exceeding the number of advancing stocks, says Anuj Sin...
20 Aug 202111min
90: Building Unicorns Podcast: Unacademy's growth strategy different, not building a conglomerate like Byju's, says Gaurav Munjal
Catch Gaurav Munjal, co-founder and CEO of Unacademy in a rapid-fire chat with CNBC-TV18’s Mugdha Variyar in this edition of the Building Unicorns podcast. Munjal says Netflix is his biggest competi...
20 Aug 202123min
89: COVID Fight Podcast: US could begin with boosters in Sep; Pfizer, AstraZeneca shots less effective against Delta, says study
A study led by researchers at the University of Oxford says that Pfizer and AstraZeneca COVID-19 vaccines are less effective against the Delta variant of coronavirus compared to the Alpha variant. M...
19 Aug 20216min
88: COVID Fight Podcast: Delta plus not a worrying factor; Delta can’t evade vaccine generated antibodies, says study
Maharashtra COVID task force member Dr Shashank Joshi said on August 18 that Delta plus variant of coronavirus is not a worrying factor as it is forming less than one percent of the current strain. M...
18 Aug 20216min
